Worsening Neurologic Symptoms in a Brain Tumor Patient
Neurol 85:e57-e61, Faivre, G.,et al, 2015
Clinicopathologic Conference, Glioblastoma, WHO Grade IV, Involving Leptomeninges Consistent with Primary Leptomeningeal Gliomatosis
NEJM 370:1049-1059, Case 8-2014, 2014
Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012
Peri-ictal Pseudoprogression in Patients with Brain Tumor
Neuro Oncol 13:775-782, Rheims, S.,et al, 2011
Brain Tumors
NEJM 344:114-123, DeAngelis,L.M., 2001
Intracranial Tumours that Mimic Transient Cerebral Ischaemia:Lessons from a Large Multicentre Trial
The UK TIA Study Group, JNNP 56:563-5661993., , 1993
Clinical Outcome in Aggressively Treated Meningeal Gliomatosis
Neurol 42:252-254, Grant,R.,et al, 1992
Brain Tumors in Children
J Pediatr 114:511-519, Kadota,R.P.,et al, 1989
Malignant Optic Gliomas in Adults
Arch Neurol 35:731-735, Harper,C.G.,et al, 1978
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Primary Brain Tumours in Adults
Lancet 402:1564-1579, van den Bent,M.,et al, 2023
Brain Tumors in Children
NEJM 386:1922-1931, Cohen, A.R., 2022
Association of Brain Cancer with Risk of Suicide
JAMA doi:10.1001/JAMANETWORKOPEN.2020.3862, Saad, A.M.,et al, 2020
Recurrent Glioblastoma Treated with Recombinant Poliovirus
NEJM 379:150-161,194, Desjardins,A., et al, 2018
Short-Course Radiation Plus Temozolomide in Elderly Patients with Glioblastoma
NEJM 376:1027-1037, Perry, J.R.,et al, 2017
Interim Results from the CATNON trial (EORTC study 260-53-22054) of treatment with Concurrent and Adjuvant Temozolomide for 1p/19q non-co-deleted anaplastic glioma: A phase 3, randomized, open-label intergroup study
Lancet 390:1645-1653, Van Den Bent, M.J.,et al, 2017
Clinical Pathologic Conference, A 20-Year-Old Man with Back Pain and Lower Extremity Weakness
JAMA Neurol 72:363-366, Etherton, M.R.,et al, 2015
Maintenance Therapy with Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
JAMA 314:2535-2543,2511, Stupp, R.,et al, 2015
Bevacizumab in Glioblastoma - Still Much to Learn
NEJM 370:764-765, Fine, H.A., 2014
Intracranial Neoplasms and Paraneoplastic Disorders, Glioblastoma Multiforme
Adams & Victors Principles of Neurology, Chp 31, pg 650, Ropper, A.H.,et al, 2014
Plasmablastic Lymphoma after Standard-Dose Temozolomide for Newly Diagnosed Glioblastoma
Neurol 81:93-94, Clark, S.,et al, 2013
A 21-year old Woman with Multiple Cancers and a New Brain Lesion
Neurol 78:743-749, Schiff,D.,et al, 2012
Persistent Diffusion-Restricted Lesions in Bevacizumab-Treated Malignant Gliomas are Associated with Improved Survival Compared with Matched Controls
AJNR 33:1763-1770, Mong, S.,et al, 2012
Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011
Functional Outcome After Language Mapping for Glioma Resection
NEJM 358:18-27, Sanai,N.,et al, 2008
Malignant Gliomas in Adults
NEJM 359:492-507, Wen,P.Y. &Kesari,S., 2008
Familiality in Brain Tumors
Neurol 71:1015-1020, Blumenthal,D.T.&Cannon-Albright,L.A., 2008
Radiotherapy for Glioblastoma in the Elderly
NEJM 356:1527-1535, Keime-Guibert,F.,et al, 2007
Glioma Therapy in Adults
The Neurologist 12:279-292, Norden,A.D. &Wen,P.Y., 2006
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
NEJM 352:987-996, 1036, Stupp,R., et al, 2005
MGMT Gene Silencing and Benefit From Temozolomide in Glioblastoma
NEJM 352:997-1003, 1036, Hegi,M.E., et al, 2005
Patterns of Care for Adults With Newly Diagnosed Malignant Glioma
JAMA 293:557-564,615, Chang,S.M.,et al, 2005
Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003
Tumor-free Survival of 7 Years After Gene Therapy for Recurrent Glioblastoma
Neurol 61:270-271, Floeth,F.W,,et al, 2003
Glioblastoma in Kidney Transplant Recipients. Report of Five Cases
J Neurooncol 63:33-37, Salvati,M.,et al, 2003
Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002
Brain Tumors in Children
Arch Neurol 56:421-425, Packer,R.J., 1999
High Incidence of Secondary Brain Tumours after Radiotherapy and Antimetabolites
Lancet 354:34-39, Relling,M.V.,et al, 1999
Which Glioblastoma Multiforme Patient Will Become a Long-Term Survivor? A Population-Based Study
Ann Neurol 46:183-188, Scott,J.N.,et al, 1999
Brain Tumors in the Elderly
Arch Neurol 55:922-928, Lowry,J.K.,et al, 1998
Herpes Simplex Encephalitis (HSE) and the Immunocompromised: A Clinical and Autopsy Study of HSE in the Settings of Cancer and Human Immunodeficiency Virus-Type 1 Infection
Hum Pathol 29:215-222, Schiff,D. &Rosenblum,M.K., 1998
Chemotherapy of Human Malignant Glioma:Prevention of Efficacy by Dexamethasone
Neurol 48:1704-1709, Weller,M.,et al, 1997
Management of Primary Malignant Brain Tumours
JNNP 60:2-5, Whittle,I.R., 1996
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Malignant Supratentorial Glioma in the Elderly:Is Radiotherapy Useful
Neurol 47:901-905, Meckling,S.,et al, 1996
The Course of Seizure Disorders in Patients with Malignant Gliomas
Arch Neurol 52:717-724, Moots,P.L.,et al, 1995
Adjuvant Therapy with Dibromodulcitol and BCNU Increased Survival of Adults with Malignant Gliomas
Neurol 44:1479-1483, Hildebrand,J.,et al, 1994
The Limited Value of Cytoreductive Surgery in Elderly Patients with Malignant Gliomas
Neurosurg 34:62-67, Kelly,P.J.&Hunt,C., 1994
Brain Tumors in Children
NEJM 331:1500-1507, Pollack,I.F., 1994